Vybio: Funding, Investors & Team (Sep 2026)
Vybio is a high-tech enterprise focusing on innovative drug research and development.
Vybio has raised $14.1M across 1 funding round on record, the most recent a Series B of $14.1M announced in Nov 2025.
That round is below the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vybio Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Vybio Funding Rounds
Vybio Founders and Leadership Team
Contact details for the Vybio team: 1 of 1 has an email address on file.
Start 14-day free trial →Vybio Funding Compared to Other Biotechnology Startups
Vybio's latest round of $14.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vybio in Biotechnology and Hangzhou
Companies Similar to Vybio
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Brise Pharma operates in the scientific research and technical service industry.
HiDiamond Biotechnology is a biopharmaceutical company offering research and development for therapeutic…
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary…
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates…
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
Vybio Funding FAQs
What does Vybio do?
Vybio is a high-tech enterprise focusing on innovative drug research and development.
How much funding has Vybio raised?
Vybio has raised $14.1M across 1 round on record. The most recent is a Series B of $14.1M announced in Nov 2025.
When did Vybio last raise funding?
Vybio's most recent funding round on record is a Series B of $14.1M, announced in Nov 2025.
Where is Vybio headquartered?
Vybio is based in Hangzhou, China.
How does Vybio's funding compare to other Biotechnology startups?
Vybio's latest round of $14.1M is below the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's Vybio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vybio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.